Xpert CT/NG Catalog GXCT/NG-120 Batch 1000049568, Catalog GXCT/NG-10 Batch 1000053075, Catalog GX...
FDA Device Recall #Z-0592-2018 — Class II — October 9, 2017
Recall Summary
| Recall Number | Z-0592-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 9, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Cepheid |
| Location | Sunnyvale, CA |
| Product Type | Devices |
| Quantity | 3,586 kits (49,400 units) |
Product Description
Xpert CT/NG Catalog GXCT/NG-120 Batch 1000049568, Catalog GXCT/NG-10 Batch 1000053075, Catalog GXCT/NG-10 Batch 1000056156 and Catalog GXCT/NG-10 Batch 1000056157. Is a qualitative in vitro real-time PCR test.
Reason for Recall
Cepheid has received reports that some of our customers have experienced a higher number of temperature drift errors than would typically be expected when using this test and its intended use specimen types. Investigation of the issue also revealed an occasional probability of false negative results which remains consistent with package insert claims.
Distribution Pattern
Worldwide Distribution -- USA, Puerto Rico, and Haiti.
Lot / Code Information
Lot numbers: 25718, 25719, 25725, and 25727.
Other Recalls from Cepheid
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0724-2026 | Class II | Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10. | Nov 5, 2025 |
| Z-0960-2026 | Class II | Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog... | Oct 30, 2025 |
| Z-0959-2026 | Class II | Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog... | Oct 30, 2025 |
| Z-0414-2026 | Class II | Xpert SA Nasal Complete Catalog Number: GXSACO... | Aug 6, 2025 |
| Z-2584-2024 | Class II | Cepheid, Sample Collection Device, Part: 900-0370 | Jun 20, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.